| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
21,111 |
20,246 |
$4.10M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,796 |
14,905 |
$3.92M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
12,174 |
11,246 |
$3.33M |
| G0378 |
Hospital observation service, per hour |
3,911 |
3,277 |
$2.41M |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
43,664 |
11,239 |
$1.42M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
63,476 |
15,251 |
$1.25M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
857 |
830 |
$971K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,000 |
4,826 |
$642K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,749 |
1,418 |
$605K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,404 |
3,278 |
$486K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,995 |
1,008 |
$377K |
| OP370 |
|
5,973 |
5,483 |
$359K |
| OP250 |
|
42,138 |
28,469 |
$353K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,784 |
12,458 |
$301K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
5,160 |
3,924 |
$260K |
| 80053 |
Comprehensive metabolic panel |
31,907 |
26,684 |
$245K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
7,242 |
6,356 |
$242K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
7,745 |
2,284 |
$236K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,936 |
4,654 |
$236K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,933 |
1,845 |
$231K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
6,406 |
2,398 |
$217K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
5,961 |
1,682 |
$211K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
785 |
757 |
$210K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,788 |
1,226 |
$205K |
| OP710 |
|
3,750 |
3,433 |
$203K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
217 |
212 |
$201K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
36,983 |
28,792 |
$197K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,460 |
3,422 |
$197K |
| 97162 |
|
4,074 |
3,962 |
$178K |
| OP272 |
|
5,319 |
4,803 |
$169K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
7,379 |
2,302 |
$154K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,758 |
5,994 |
$139K |
| 76830 |
Ultrasound, transvaginal |
1,857 |
1,810 |
$138K |
| 96367 |
|
1,738 |
1,029 |
$137K |
| 71046 |
Radiologic examination, chest; 2 views |
6,435 |
6,204 |
$117K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,437 |
1,395 |
$114K |
| 93970 |
|
511 |
487 |
$113K |
| 50590 |
|
101 |
93 |
$112K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
112 |
109 |
$112K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,157 |
1,079 |
$109K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
9,174 |
8,503 |
$107K |
| 93971 |
|
793 |
759 |
$99K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
2,873 |
2,377 |
$97K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
3,411 |
3,191 |
$90K |
| 76642 |
|
1,144 |
1,095 |
$76K |
| 36415 |
Collection of venous blood by venipuncture |
33,926 |
27,186 |
$69K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,602 |
2,060 |
$67K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
64 |
62 |
$67K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,641 |
2,602 |
$66K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,578 |
3,233 |
$64K |
| 93975 |
|
393 |
375 |
$63K |
| 97161 |
|
1,712 |
1,633 |
$61K |
| 71045 |
Radiologic examination, chest; single view |
6,414 |
6,020 |
$59K |
| 72110 |
|
1,488 |
1,446 |
$57K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,804 |
1,657 |
$56K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,238 |
4,148 |
$52K |
| C1776 |
Joint device (implantable) |
18 |
14 |
$52K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
346 |
334 |
$51K |
| OP279 |
|
2,148 |
2,005 |
$51K |
| 71250 |
|
474 |
450 |
$50K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,177 |
1,158 |
$49K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
4,258 |
2,699 |
$48K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
319 |
301 |
$44K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,367 |
2,252 |
$43K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,795 |
3,502 |
$41K |
| 97116 |
|
3,267 |
1,427 |
$39K |
| 73564 |
|
1,183 |
1,082 |
$38K |
| 77080 |
|
674 |
657 |
$37K |
| 73630 |
|
1,584 |
1,502 |
$36K |
| 84484 |
|
8,982 |
7,672 |
$34K |
| 73130 |
|
1,514 |
1,431 |
$33K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,098 |
1,984 |
$33K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,108 |
1,065 |
$32K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
121 |
118 |
$30K |
| 73030 |
|
1,152 |
1,080 |
$27K |
| 85610 |
|
9,934 |
8,279 |
$27K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
4,523 |
3,664 |
$25K |
| 74018 |
|
1,608 |
1,479 |
$23K |
| 97163 |
|
519 |
511 |
$23K |
| OP259 |
|
5,745 |
4,820 |
$23K |
| 80061 |
Lipid panel |
2,672 |
2,539 |
$22K |
| 82948 |
|
3,557 |
2,190 |
$22K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
99 |
79 |
$22K |
| 77065 |
Tomosynthesis, mammo |
435 |
404 |
$21K |
| 85730 |
|
8,236 |
7,397 |
$21K |
| 83880 |
|
2,499 |
2,338 |
$20K |
| 73610 |
|
1,078 |
1,027 |
$19K |
| 77066 |
Tomosynthesis, mammo |
269 |
253 |
$19K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
6,851 |
5,829 |
$19K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
6,104 |
5,735 |
$19K |
| 83735 |
|
7,561 |
6,347 |
$18K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
229 |
215 |
$18K |
| 82550 |
|
6,300 |
5,740 |
$17K |
| 84439 |
|
1,276 |
1,164 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,751 |
3,004 |
$16K |
| 73560 |
|
523 |
486 |
$16K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,759 |
3,072 |
$15K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,624 |
2,495 |
$15K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
735 |
531 |
$15K |
| 86901 |
|
2,329 |
2,113 |
$15K |
| 87040 |
|
2,586 |
2,412 |
$14K |
| 84702 |
|
2,259 |
2,126 |
$14K |
| 81001 |
|
9,231 |
8,775 |
$14K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,164 |
1,112 |
$14K |
| A9270 |
Non-covered item or service |
9,486 |
4,010 |
$14K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
36 |
36 |
$14K |
| OP258 |
|
17,632 |
10,299 |
$14K |
| 82248 |
|
1,171 |
969 |
$14K |
| 97164 |
|
353 |
330 |
$13K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,281 |
1,131 |
$13K |
| 86900 |
|
2,292 |
2,117 |
$12K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,627 |
2,968 |
$12K |
| J2704 |
Injection, propofol, 10 mg |
4,789 |
4,033 |
$11K |
| 83690 |
|
6,357 |
5,914 |
$11K |
| 84703 |
|
4,742 |
4,528 |
$11K |
| 72100 |
|
582 |
531 |
$10K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
407 |
392 |
$10K |
| 86850 |
|
1,597 |
1,394 |
$9K |
| 87081 |
|
4,494 |
4,410 |
$9K |
| 81003 |
|
5,263 |
5,038 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
688 |
668 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,110 |
4,038 |
$8K |
| 0240U |
|
366 |
350 |
$8K |
| 93017 |
|
60 |
56 |
$8K |
| 96376 |
|
1,434 |
1,149 |
$8K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
471 |
428 |
$8K |
| OP270 |
|
882 |
702 |
$8K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,790 |
2,245 |
$7K |
| 82728 |
|
756 |
727 |
$7K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,130 |
1,494 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
369 |
239 |
$7K |
| 97014 |
|
877 |
273 |
$6K |
| 82962 |
|
4,536 |
2,918 |
$6K |
| 83605 |
|
1,476 |
1,324 |
$6K |
| 84100 |
|
3,457 |
3,003 |
$6K |
| 72050 |
|
108 |
108 |
$6K |
| 92567 |
|
77 |
75 |
$6K |
| 88342 |
|
477 |
458 |
$6K |
| 87186 |
|
1,634 |
1,544 |
$6K |
| 87428 |
|
436 |
417 |
$6K |
| 73110 |
|
273 |
260 |
$6K |
| 0001A |
|
182 |
182 |
$5K |
| 84481 |
|
230 |
216 |
$5K |
| 0002A |
|
174 |
174 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
382 |
370 |
$5K |
| 82607 |
|
432 |
420 |
$5K |
| 83540 |
|
1,161 |
1,083 |
$5K |
| 87077 |
|
1,231 |
1,170 |
$5K |
| 85379 |
|
1,932 |
1,856 |
$4K |
| 94060 |
|
25 |
24 |
$4K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
184 |
183 |
$4K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,493 |
1,182 |
$4K |
| 73502 |
|
268 |
265 |
$4K |
| 85652 |
|
1,170 |
1,071 |
$4K |
| 82553 |
|
662 |
585 |
$4K |
| 72170 |
|
166 |
157 |
$4K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
12 |
12 |
$4K |
| 83550 |
|
533 |
517 |
$3K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
113 |
106 |
$3K |
| 88313 |
|
860 |
834 |
$3K |
| 86141 |
|
833 |
811 |
$3K |
| 76536 |
|
52 |
49 |
$3K |
| 97166 |
|
78 |
71 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
393 |
364 |
$3K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
5,811 |
5,094 |
$3K |
| 82150 |
|
1,519 |
1,464 |
$3K |
| 92557 |
|
12 |
12 |
$2K |
| 84466 |
|
624 |
541 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
326 |
291 |
$2K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
27 |
27 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
276 |
270 |
$2K |
| 87070 |
|
355 |
337 |
$2K |
| 73562 |
|
117 |
113 |
$2K |
| 76775 |
|
41 |
41 |
$2K |
| 87205 |
|
592 |
530 |
$2K |
| 85027 |
|
867 |
637 |
$2K |
| C1769 |
Guide wire |
283 |
245 |
$2K |
| 70486 |
|
41 |
40 |
$2K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
81 |
77 |
$2K |
| 90715 |
|
214 |
208 |
$2K |
| 36591 |
|
145 |
90 |
$2K |
| 87807 |
|
609 |
606 |
$2K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
28 |
26 |
$2K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
65 |
62 |
$2K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
13 |
12 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
15 |
15 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,353 |
1,255 |
$2K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
40 |
37 |
$1K |
| 0004A |
|
40 |
40 |
$1K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
860 |
768 |
$1K |
| 88304 |
|
56 |
53 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
198 |
122 |
$1K |
| 86140 |
|
506 |
465 |
$1K |
| 87088 |
|
532 |
497 |
$1K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,892 |
1,378 |
$1K |
| 88312 |
|
742 |
716 |
$1K |
| J1756 |
Injection, iron sucrose, 1 mg |
60 |
27 |
$1K |
| 81025 |
|
1,305 |
1,212 |
$1K |
| 94729 |
|
25 |
24 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
680 |
537 |
$988.35 |
| 0012A |
|
25 |
25 |
$889.94 |
| 0011A |
|
25 |
25 |
$849.94 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
497 |
459 |
$788.97 |
| 85007 |
|
539 |
395 |
$771.19 |
| 96368 |
|
43 |
37 |
$765.43 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
506 |
483 |
$754.82 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
530 |
498 |
$754.82 |
| OP637 |
|
747 |
392 |
$734.40 |
| 94727 |
|
25 |
24 |
$730.43 |
| 97165 |
|
27 |
27 |
$708.98 |
| 12001 |
|
29 |
25 |
$675.04 |
| 0064A |
|
18 |
18 |
$630.78 |
| 87147 |
|
734 |
725 |
$590.24 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,292 |
670 |
$552.45 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
94 |
69 |
$539.55 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
89 |
65 |
$538.55 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
30 |
29 |
$535.53 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
276 |
240 |
$497.21 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
681 |
565 |
$451.38 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
196 |
175 |
$447.62 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
43 |
28 |
$435.98 |
| 74022 |
|
41 |
40 |
$430.23 |
| 82746 |
|
95 |
89 |
$393.52 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
13 |
13 |
$364.94 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
116 |
101 |
$350.72 |
| 74019 |
|
30 |
28 |
$324.94 |
| 82784 |
|
46 |
38 |
$270.03 |
| 72040 |
|
15 |
14 |
$252.39 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
254 |
243 |
$221.74 |
| J1644 |
Injection, heparin sodium, per 1000 units |
602 |
271 |
$208.01 |
| G0123 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
13 |
13 |
$198.56 |
| 84145 |
|
66 |
61 |
$188.32 |
| 80143 |
|
47 |
44 |
$170.51 |
| 80320 |
|
71 |
62 |
$155.93 |
| 80179 |
|
42 |
41 |
$132.53 |
| 86334 |
|
15 |
12 |
$131.29 |
| 88311 |
|
39 |
27 |
$122.81 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
410 |
245 |
$122.71 |
| 87075 |
|
13 |
12 |
$119.80 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
394 |
361 |
$112.39 |
| 75571 |
|
91 |
85 |
$107.99 |
| 29125 |
|
26 |
26 |
$106.91 |
| J3490 |
Unclassified drugs |
39 |
37 |
$98.46 |
| 82247 |
|
184 |
165 |
$74.66 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
135 |
124 |
$66.69 |
| 81015 |
|
114 |
105 |
$63.61 |
| 84075 |
|
118 |
107 |
$62.95 |
| 84165 |
|
16 |
13 |
$58.77 |
| 83615 |
|
25 |
24 |
$58.29 |
| 84450 |
|
118 |
107 |
$50.98 |
| 84460 |
|
119 |
108 |
$50.04 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
60 |
54 |
$47.69 |
| J2060 |
Injection, lorazepam, 2 mg |
217 |
171 |
$38.49 |
| 82040 |
|
122 |
110 |
$31.12 |
| 84155 |
|
118 |
107 |
$31.12 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
26 |
13 |
$25.65 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
170 |
165 |
$13.57 |
| 91300 |
|
69 |
67 |
$5.00 |
| J7510 |
Prednisolone oral, per 5 mg |
12 |
12 |
$3.00 |
| J0687 |
Injection, cefazolin sodium (wg critical care), not therapeutically equivalent to j0690, 500 mg |
81 |
74 |
$2.61 |
| J1815 |
Injection, insulin, per 5 units |
76 |
24 |
$2.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
96 |
49 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
97 |
50 |
$0.00 |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
13 |
12 |
$0.00 |